English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Xinnong’s pyraclostrobin project to begin trial production between end of 2019, start of 2020qrcode

Sep. 4, 2019

Favorites Print
Forward
Sep. 4, 2019

Xinnong’s pyraclostrobin project to begin trial production between end of 2019, start of 2020

According to its report for the first half of 2019, Zhejiang Xinnong Chemical recorded earnings of Yuan 542.08 million, a 3.24% increase year on year, and a net profit attributable to its mother company of Yuan 103.71386066 million, up 18.61% year on year. 

During the period covered by the report, Xinnong Chemical intensified its fundraising efforts, and its four projects funded by raised proceeds are progressing according to plan. As well as a 6,600-ton environmentally friendly water-based formulations production line and auxiliaries, phase one of a 2,800-ton fungicide (suspending formulation) production line-oriented main works and a pollution control facility have been completed and entered trial production. These measures will increase production efficiency by utilizing a continuous production process and smart management system, while supporting the company’s future business growth. 
 
The company’s pyraclostrobin project is divided into various planned phases. Phase one is progressing smoothly, and the project is expected to enter trial production between the end of 2019 and the start of 2020.
 
Xinnong Chemical’s report also notes that spending on research and development was Yuan 26.9389 million, 14.02% up year on year.
 
Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox